|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| A61K 31/713 | |||
| A61K 31/7088 | |||
| A61K 31/59 | |||
| A61K 38/17 | |||
| A61K 38/18 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61L 27/12 | |||
| A61L 27/54 |
| (11) | Number of the document | 2144613 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07875255.7 |
| Date of filing the European patent application | 2007-12-21 | |
| (97) | Date of publication of the European application | 2010-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/088542 |
| Date | 2007-12-21 |
| (87) | Number | WO 2009/131553 |
| Date | 2009-10-29 |
| (30) | Number | Date | Country code |
| 882642 P | 2006-12-29 | US |
| (72) |
ELLIES, Debra, L., US
|
| (73) |
Ossifi-Mab LLC ,
11235 Mastin Street, Suite 102
Overland Park, Kansas 66210,
US
|
| (54) | METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST |
| METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST |